Rombotis Spiro

Avg. Two Year Performance

(62%) Avg. Purchase Return
(27%) Compound
76% Avg. Sale Return
33% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)(9%)24%(11%)(62%)
Purchase Success Rate5 of 143 of 144 of 144 of 143 of 14
Average Sale Return26%38%37%48%76%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1
Drugs » Biotechnology

President and CEO, Director:

Holdings: 68.66K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--